Building genomic capacity for precision health in Africa

A Olono, V Mitesser, A Happi, C Happi - Nature Medicine, 2024 - nature.com
The African continent is poised to have a pivotal role in the global population landscape,
with the United Nations projecting a population of 2.5 billion (more than 25% of the global …

[HTML][HTML] ERα-associated translocations underlie oncogene amplifications in breast cancer

JJK Lee, YL Jung, TC Cheong, J Espejo Valle-Inclan… - Nature, 2023 - nature.com
Focal copy-number amplification is an oncogenic event. Although recent studies have
revealed the complex structure,–and the evolutionary trajectories of oncogene amplicons …

[HTML][HTML] Outcomes in breast cancer—does ethnicity matter?

YS Yap - ESMO open, 2023 - Elsevier
Ethnic or racial differences in breast cancer (BC) survival outcomes have been reported, but
current data are largely restricted to comparisons between African Americans and non …

Race, gene expression signatures, and clinical outcomes of patients with high-risk early breast cancer

B Kyalwazi, C Yau, MJ Campbell… - JAMA Network …, 2023 - jamanetwork.com
Importance There has been little consideration of genomic risk of recurrence by breast
cancer subtype despite evidence of racial disparities in breast cancer outcomes. Objective …

Racial disparities in pathological complete response among patients receiving neoadjuvant chemotherapy for early-stage breast cancer

F Zhao, M Miyashita, M Hattori, T Yoshimatsu… - JAMA network …, 2023 - jamanetwork.com
Importance Among patients with breast cancer, inconsistent findings have been published
on racial disparities in achieving pathologic complete response (pCR) after neoadjuvant …

Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma

N Ansari-Pour, M Samur, E Flynt, S Gooding, F Towfic… - Blood, 2023 - ashpublications.org
Large-scale analyses of genomic data from patients with newly diagnosed multiple myeloma
(ndMM) have been undertaken, however, large-scale analysis of relapsed/refractory MM …

Multi-scale characterisation of homologous recombination deficiency in breast cancer

DH Jacobson, S Pan, J Fisher, M Secrier - Genome Medicine, 2023 - Springer
Background Homologous recombination is a robust, broadly error-free mechanism of double-
strand break repair, and deficiencies lead to PARP inhibitor sensitivity. Patients displaying …

Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology

B Kinnersley, A Sud, A Everall, AJ Cornish, D Chubb… - Nature Genetics, 2024 - nature.com
Tumor genomic profiling is increasingly seen as a prerequisite to guide the treatment of
patients with cancer. To explore the value of whole-genome sequencing (WGS) in …

An elevated rate of whole-genome duplications in cancers from Black patients

LM Brown, RA Hagenson, T Koklič, I Urbančič… - Nature …, 2024 - nature.com
Abstract In the United States, Black individuals have higher rates of cancer mortality than
any other racial group. Here, we examine chromosome copy number changes in cancers …

Landmark series: the cancer genome atlas and the study of breast cancer disparities

JA Johnson, BJ Moore, G Syrnioti, CM Eden… - Annals of Surgical …, 2023 - Springer
Race-related variation in breast cancer incidence and mortality are well-documented in the
United States. The effect of genetic ancestry on disparities in tumor genomics, risk factors …